|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 19 of 200 found articles
| Title: |
120O Pembrolizumab (Pembro) with or without lenvatinib (Lenva) in first-line metastatic NSCLC with PD-L1 TPS ≥1% (LEAP-007): A phase III, randomized, double-blind study |
| Author: |
Yang, J.C-H. Luft, A. De La Mora Jiménez, E. Lee, J.S. Koralewski, P. Karadurmus, N. Sugawara, S. Livi, L. Basappa, N.S. Quantin, X. Dudnik, J. Moran Ortiz, D. Mekhail, T. Okpara, C.E. Zimmer, Z. Samkari, A. Bhagwati, N. Csőszi, T. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 32 () nr. S7 pages S1429-S1430 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 19 of 200 found articles
| << previous | next >> |